Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer

Abstract excerpt

BACKGROUND: in the prediction and prognosis of CRC through long-term clinical observation. AIM: in patients with stage II-III CRC using immunohistochemical analysis and GeneScan. METHODS: Specimens from 681 patients with CRC (395 stage II and 286 stage III, 387 males and 294 females) who underwent curative surgical resection from 2013 to 2016 were tested. Immunohistochemistry was used to analyze MMR status and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Colorectal Cancer Surgical Treatments
• Share to Colorectal Cancer Treatments and Studies
• Share to Genetic factors in colorectal cancer